Clariant (SWX:CLN) has drawn fresh attention after reporting half year 2026 earnings that combined lower sales with higher profitability, including stronger net income and earnings per share from continuing operations.
See our latest analysis for Clariant.
The latest half year earnings and the favorable court ruling at the end of July appear to have supported sentiment around Clariant, with the CHF10.10 share price reflecting a 35.39% 1 month share price return and a 41.95% year to date share price return, even though the 3 year total shareholder return declined 17.15% and the 5 year total shareholder return declined 37.88%. This suggests short term momentum has improved while longer term holders are still recovering.
If Clariant's recent move has you rethinking where growth could come from next, it may be worth scanning the market for other materials and energy enablers through the 37 power grid technology and infrastructure stocks
After a sharp rerating on the back of stronger profitability and the court win, Clariant now raises a tougher question for new money: Does the current valuation still leave enough upside to justify the risks?
Clariant's most followed narrative points to a fair value of CHF8.58, which sits below the recent CHF10.10 share price and frames the current optimism carefully.
The analysts have a consensus price target of CHF8.58 for Clariant based on their expectations of its future earnings growth, profit margins and other risk factors.
However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of CHF11.0, and the most bearish reporting a price target of just CHF6.0.
Want to see what sits behind that CHF8.58 fair value and the wide analyst spread? The narrative leans heavily on modest revenue growth, margin rebuild, and a reset earnings base.
Result: Fair Value of CHF8.58 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Clariant's heavier exposure to China and rising compliance and restructuring costs could pressure margins and earnings, which would challenge the current optimistic narrative.
Find out about the key risks to this Clariant narrative.
The analyst narrative suggests Clariant is 17.7% overvalued around CHF10.10. Our cash flow based view is very different. The SWS DCF model points to a future cash flow value of CHF31.91, which is 68.3% above the current share price and indicates a very wide gap to market pricing.
That kind of spread between what the DCF implies and what the analyst target suggests raises a simple question for you. Is the risk higher that cash flows fall short of the model, or that the market is underpricing a specialty chemicals turnaround story?
Look into how the SWS DCF model arrives at its fair value.
After all this, does the mixed sentiment around Clariant leave you curious rather than convinced? Act while the latest information is still fresh and weigh the trade off between its risks and potential rewards using these 3 key rewards and 3 important warning signs
If Clariant has sharpened your focus, now is the moment to scan other opportunities so you do not miss stocks that better match your goals.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com